PL375527A1 - Arylokarbonylopiperazyny i heteroarylokarbonylopiperazyny oraz ich zastosowanie do leczenia łagodnych i złośliwych chorób nowotworowych - Google Patents
Arylokarbonylopiperazyny i heteroarylokarbonylopiperazyny oraz ich zastosowanie do leczenia łagodnych i złośliwych chorób nowotworowychInfo
- Publication number
- PL375527A1 PL375527A1 PL03375527A PL37552703A PL375527A1 PL 375527 A1 PL375527 A1 PL 375527A1 PL 03375527 A PL03375527 A PL 03375527A PL 37552703 A PL37552703 A PL 37552703A PL 375527 A1 PL375527 A1 PL 375527A1
- Authority
- PL
- Poland
- Prior art keywords
- heteroarylcarbonylpiperazines
- arylcarbonylpiperazines
- malignant tumour
- treating benign
- tumour diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39302702P | 2002-06-29 | 2002-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL375527A1 true PL375527A1 (pl) | 2005-11-28 |
Family
ID=30000964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03375527A PL375527A1 (pl) | 2002-06-29 | 2003-06-20 | Arylokarbonylopiperazyny i heteroarylokarbonylopiperazyny oraz ich zastosowanie do leczenia łagodnych i złośliwych chorób nowotworowych |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20040097734A1 (pl) |
| EP (1) | EP1517898A1 (pl) |
| JP (1) | JP2005538968A (pl) |
| CN (1) | CN100509790C (pl) |
| AR (1) | AR040315A1 (pl) |
| AU (1) | AU2003246571B2 (pl) |
| BR (1) | BR0312294A (pl) |
| CA (1) | CA2433983A1 (pl) |
| HR (1) | HRP20050092A2 (pl) |
| MX (1) | MXPA04012959A (pl) |
| NO (1) | NO20050428L (pl) |
| NZ (1) | NZ537916A (pl) |
| PL (1) | PL375527A1 (pl) |
| RU (1) | RU2335496C2 (pl) |
| UA (1) | UA79286C2 (pl) |
| WO (1) | WO2004002965A1 (pl) |
| ZA (1) | ZA200409610B (pl) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0407088A (pt) * | 2003-01-28 | 2006-01-24 | Aventis Pharma Sa | Produtos n-aril-heteroaromáticos, composições contendo os mesmos e seu uso |
| JP2006525355A (ja) * | 2003-05-01 | 2006-11-09 | アボット・ラボラトリーズ | ナトリウムチャンネルモジュレーターとしてのピラゾール−アミドおよびスルホンアミド |
| PE20050226A1 (es) * | 2003-06-04 | 2005-05-18 | Aventis Pharma Sa | Productos aril-heteroaromaticos y composiciones que los contienen |
| FR2855825B1 (fr) * | 2003-06-04 | 2008-08-22 | Aventis Pharma Sa | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
| EP1645556A1 (en) * | 2004-10-07 | 2006-04-12 | Boehringer Ingelheim International GmbH | Arylpiperazine-benzoylamide derivatives useful as pharmaceutical agents |
| JP5149177B2 (ja) | 2005-07-25 | 2013-02-20 | シンタ ファーマシューティカルズ コーポレーション | 増殖性疾患の治療のための、チューブリンポリマー化の１，２，３−トリアゾール系抑制剤 |
| AU2007275301A1 (en) * | 2006-07-20 | 2008-01-24 | Amgen Inc. | Substituted azole aromatic heterocycles as inhibitors of 11-beta-HSD-1 |
| KR100932093B1 (ko) | 2006-09-27 | 2009-12-16 | 주식회사종근당 | 미세소관 형성 저해제로서 유용한 벤조페논 유도체 |
| JP5220858B2 (ja) * | 2007-08-13 | 2013-06-26 | エフ．ホフマン−ラ ロシュ アーゲー | 新規ピペラジンアミド誘導体 |
| CN101597278B (zh) | 2008-06-04 | 2013-04-17 | 中国中化股份有限公司 | 酰胺类化合物及其制备与应用 |
| US9212177B2 (en) * | 2009-08-05 | 2015-12-15 | Versitech Limited | Antiviral compounds and methods of making and using thereof |
| US20120142701A1 (en) * | 2010-05-28 | 2012-06-07 | The University Of Hong Kong | Compounds and methods for the treatment of proliferative diseases |
| KR101369584B1 (ko) * | 2011-04-19 | 2014-03-06 | 일양약품주식회사 | 페닐-이속사졸 유도체 및 그의 제조방법 |
| US11084807B2 (en) | 2016-08-18 | 2021-08-10 | Vidac Pharama Ltd. | Piperazine derivatives, pharmaceutical compositions and methods of use thereof |
| EP4464334A3 (en) * | 2016-11-07 | 2025-01-08 | VIDAC Pharma Ltd. | Use of compounds for treating hk2-expressing cancers |
| US10682346B2 (en) | 2016-11-07 | 2020-06-16 | Vidac Pharma Ltd. | Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses |
| RU2700576C1 (ru) * | 2019-05-07 | 2019-09-18 | Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") | Анксиолитическое средство |
| CN111303132B (zh) * | 2020-03-19 | 2023-05-23 | 辽宁孚音生物科技有限公司 | 一种抗癌化合物及其制备方法和应用 |
| KR20240023691A (ko) * | 2020-08-12 | 2024-02-22 | 스프루스 바이오사이언시스 인코포레이티드 | 다낭성 난소 증후군을 치료하기 위한 방법 및 조성물 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1620016C3 (de) * | 1966-07-02 | 1979-08-30 | Merck Patent Gmbh, 6100 Darmstadt | 3-{Piperazinoalkyl)-pyrazole und Verfahren zu ihrer Herstellung |
| US3468882A (en) * | 1966-10-07 | 1969-09-23 | Sterling Drug Inc | Phenylhydrazone derivatives as intermediates for preparing indoles |
| BE791501A (fr) * | 1971-11-19 | 1973-05-17 | Albert Ag Chem Werke | Diamines cycliques n,n'-disubstituees et leur procede de preparation |
| CA1081228A (en) * | 1976-02-18 | 1980-07-08 | Richard A. Partyka | Oxazole, isoxazole, thiazole and isothiazole amides |
| EP0385043A1 (en) * | 1989-02-28 | 1990-09-05 | Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. (Faes) | New derivatives of 4-substituted piperazines |
| JPH03218371A (ja) * | 1989-08-02 | 1991-09-25 | Takeda Chem Ind Ltd | ピラゾール誘導体 |
| US5563142A (en) * | 1989-12-28 | 1996-10-08 | The Upjohn Company | Diaromatic substituted compounds as anti-HIV-1 agents |
| US5416087A (en) * | 1990-10-10 | 1995-05-16 | Wong; Jesse K. | Bis-benzo, cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use |
| DE4219247A1 (de) * | 1992-06-12 | 1993-12-16 | Bayer Ag | Verwendung von 3-arylsubstituierten 5-Alkyl-isoxazol-4-carbonsäurederivaten zur Bekämpfung von Endoparasiten, neue 3-arylsubstituierte 5-Alkyl-isoxazol-4-carbonsäurederivate und Verfahren zu ihrer Herstellung |
| WO1994024095A1 (en) * | 1993-04-16 | 1994-10-27 | Abbott Laboratories | Immunosuppressive agents |
| US6262059B1 (en) * | 1995-06-07 | 2001-07-17 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with quinazoline derivatives |
| SK27598A3 (en) * | 1996-06-29 | 1998-11-04 | Samjin Pharm Co Ltd | Piperazine derivatives and process for the preparation thereof |
| ES2125206B1 (es) * | 1997-07-21 | 1999-11-16 | Esteve Labor Dr | Derivados de acil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos. |
| US6166203A (en) * | 1998-02-26 | 2000-12-26 | Neurogen Corporation | Heterocyclic amino substituted heteroaryl fused pyridines; GABA brain receptor ligands |
| MXPA01008142A (es) * | 1999-02-10 | 2003-07-21 | Welfide Corp | Compuestos de amida, y uso medicinal de los mismos. |
| AU3248600A (en) * | 1999-03-03 | 2000-09-21 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferases |
| CZ2002959A3 (cs) * | 1999-09-17 | 2002-07-17 | Millennium Pharmaceuticals, Inc. | Inhibitory faktoru Xa |
| DE10035928A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| DE10035908A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| DE10035927A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| WO2002020436A2 (en) * | 2000-09-05 | 2002-03-14 | Neogenesis Pharmaceuticals, Inc. | Methods for forming combinatorial libraries combining amide bond formation with epoxide opening |
| US20020072081A1 (en) * | 2000-09-06 | 2002-06-13 | Wai-Si Eng | Geranylgeranyl transferase inhibitor screening assay |
| FR2815032B1 (fr) * | 2000-10-10 | 2003-08-08 | Pf Medicament | Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations |
| DE10102053A1 (de) * | 2001-01-17 | 2002-07-18 | Merck Patent Gmbh | Piperazinylcarbonylchinoline und -isochinoline |
| ES2180456B1 (es) * | 2001-07-20 | 2004-05-01 | Laboratorios S.A.L.V.A.T., S.A. | Isoxazoles sustituidos y su utilizacion como antibioticos. |
| CN1620294A (zh) * | 2001-12-20 | 2005-05-25 | Osi药物公司 | 嘧啶a2b选择性拮抗剂化合物,它们的合成及用途 |
-
2003
- 2003-06-20 UA UA20041210297A patent/UA79286C2/uk unknown
- 2003-06-20 RU RU2005102478/04A patent/RU2335496C2/ru not_active IP Right Cessation
- 2003-06-20 JP JP2004516632A patent/JP2005538968A/ja active Pending
- 2003-06-20 MX MXPA04012959A patent/MXPA04012959A/es active IP Right Grant
- 2003-06-20 BR BR0312294-8A patent/BR0312294A/pt not_active IP Right Cessation
- 2003-06-20 AU AU2003246571A patent/AU2003246571B2/en not_active Ceased
- 2003-06-20 CN CNB038154854A patent/CN100509790C/zh not_active Expired - Fee Related
- 2003-06-20 NZ NZ537916A patent/NZ537916A/en unknown
- 2003-06-20 WO PCT/EP2003/006555 patent/WO2004002965A1/de not_active Ceased
- 2003-06-20 PL PL03375527A patent/PL375527A1/pl not_active Application Discontinuation
- 2003-06-20 EP EP03761482A patent/EP1517898A1/de not_active Withdrawn
- 2003-06-20 HR HR20050092A patent/HRP20050092A2/hr not_active Application Discontinuation
- 2003-06-27 US US10/608,520 patent/US20040097734A1/en not_active Abandoned
- 2003-06-27 AR ARP030102359A patent/AR040315A1/es unknown
- 2003-06-27 CA CA002433983A patent/CA2433983A1/en not_active Abandoned
-
2004
- 2004-11-26 ZA ZA2004/09610A patent/ZA200409610B/en unknown
-
2005
- 2005-01-25 NO NO20050428A patent/NO20050428L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20050092A2 (en) | 2005-02-28 |
| UA79286C2 (en) | 2007-06-11 |
| WO2004002965A1 (de) | 2004-01-08 |
| AU2003246571A1 (en) | 2004-01-19 |
| RU2005102478A (ru) | 2005-07-20 |
| JP2005538968A (ja) | 2005-12-22 |
| RU2335496C2 (ru) | 2008-10-10 |
| AR040315A1 (es) | 2005-03-23 |
| EP1517898A1 (de) | 2005-03-30 |
| CN1665792A (zh) | 2005-09-07 |
| CN100509790C (zh) | 2009-07-08 |
| US20040097734A1 (en) | 2004-05-20 |
| HK1080840A1 (zh) | 2006-05-04 |
| MXPA04012959A (es) | 2005-05-16 |
| CA2433983A1 (en) | 2003-12-29 |
| BR0312294A (pt) | 2005-04-12 |
| NO20050428L (no) | 2005-01-25 |
| AU2003246571B2 (en) | 2008-06-26 |
| ZA200409610B (en) | 2005-05-25 |
| NZ537916A (en) | 2005-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL164599A0 (en) | Combination therapy for the treatment of cancer | |
| PL375527A1 (pl) | Arylokarbonylopiperazyny i heteroarylokarbonylopiperazyny oraz ich zastosowanie do leczenia łagodnych i złośliwych chorób nowotworowych | |
| PL370029A1 (pl) | Pochodne 2-amino-4-heteroaryloaminopirymidyny do stosowania w leczeniu raka | |
| AU2003213144A1 (en) | Alkylating agent combinations in the treatment of cancer | |
| AU2003302892A8 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| EP1482970A4 (en) | ANTICANCER THERAPY | |
| ZA200409492B (en) | Compositions and methods for the diagnosis and treatment of tumor. | |
| EP1587837A3 (en) | Prostate cancer diagnosis and treatment | |
| ZA200408767B (en) | Immunoconjugates for the treatment of tumours | |
| AU2003212634A8 (en) | Compounds useful in the treatment of cancer | |
| IL159887A0 (en) | Combination therapy for the treatment of cancer | |
| PL373346A1 (pl) | Nowe, rozpuszczalne w wodzie związki porfirynoplatyny o wysokiej selektywności względem nowotworów i ich zastosowanie w leczeniu łagodnych i złośliwych chorób nowotworowych | |
| PL368035A1 (pl) | Kompozycje i sposoby leczenia raka | |
| GB0201498D0 (en) | Materials and methods for treating cancer | |
| LT1496918T (lt) | Natrio meta-arsenito naudojimas navikams gydyti | |
| AU2003231803A8 (en) | Treatment of cancer with mefloquire | |
| GB0226595D0 (en) | Cancer therapy determination | |
| AU2002366195A8 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
| EP1684795A4 (en) | METHODS AND AGENTS FOR THE TREATMENT OF CANCER | |
| EP1583543A4 (en) | METHOD AND THERAPEUTIC COMPOSITIONS IN THE TREATMENT OF ADVANCED CARCINOMA | |
| IL165440A0 (en) | Arylcarbonylpiperazines and heteroarylpiperazines and the use thereof for treating benign and malignant tumour diseases | |
| GB0223325D0 (en) | Treating cancer | |
| GB2383538B (en) | Cancer treatment | |
| IL147416A0 (en) | Combined modalities for improved cancer treatment | |
| AU2003268463A8 (en) | Asialo-interferons and the treatment of liver cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |